Personalised medicine is a new concept rapidly developing and changing how we approach healthcare.
The Personalised Medicine Supply Chain is a system that tracks medicines from when they are manufactured to when they are dispensed. It consists of three main parts: supply chain, logistics, and analytics.
Within the Personalised Medicine Supply Chain, FET Logistics is responsible for working with pharmaceutical companies to ensure that their products can be delivered on time to patients who need them.
The influence of personalised medicine on the pharmaceutical delivery service?
The influence of personalised medicine on pharmaceutical logistics will be significant, increasing the demand for drug development. This will result in higher costs and lead to an increase in the use of generics.
Predicting how personalised medicine will change the pharmaceutical logistics is difficult, but several changes are likely in store for this industry.
Confronting the Challenges of Personalised Medicine
Personalised medicine is a term used to describe the practice of tailoring treatments to individual patients.
Personalised medicine aims to provide the best care for each patient while reducing costs. However, many challenges come with this practice.
Some of these challenges include:
– The cost of personalised medicine is high, and it can be difficult for insurers to cover it
The cost of personalised medicine is high and can be difficult for insurers to cover, especially when patients are treated for complex conditions requiring a lot of time and effort. To provide fair treatment, the insurance company must consider the value in benefits and the likelihood that the patient will maintain their health.
– Patients may not be willing to accept the risks associated with personalised medicine
Patients may be reluctant to accept the risks associated with personalised medicine because they feel doctors are obligated to do no harm. Other reports have shown that some patients are uncomfortable with opening up their medical records and sharing information with doctors, as well as not being willing to undergo tests that could lead to a different treatment.
– There are ethical concerns about whether or not personalising treatments based on genetic information is ethical
Genetics is at the forefront of health care today. Personalised treatments are becoming more commonplace, but there are many ethical concerns about providing these treatments and what information is being gathered.
– There are ethical concerns about whether or not personalising treatments based on medical history can lead to discrimination.
Personalising treatments based on medical history can lead to discrimination, but it may also reduce health care costs and save lives. The question is whether or not the benefits outweigh the downsides.